An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Mol Ther
; 30(9): 2984-2997, 2022 09 07.
Article
in En
| MEDLINE
| ID: mdl-35484842
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Viral Vaccines
/
COVID-19
Limits:
Animals
/
Humans
Language:
En
Year:
2022
Type:
Article